正规药品被炒作成“神药”，背后是健康消费市场的乱象

Core Viewpoint - The article highlights the rampant issue of fraudulent marketing in the health consumption market, particularly targeting the elderly, where legitimate medications are misrepresented as miraculous cures at exorbitant prices, leading to financial loss and health risks for consumers [1][3][4]. Group 1: Product Misrepresentation - A legitimate traditional Chinese medicine, Kangxin Oral Liquid, was sold for 16,800 yuan as a "miraculous elixir" despite its actual market price being between 258 and 399 yuan [1][3]. - The product's actual indications do not include chronic diseases and it does not possess the claimed life-extending properties, as stated in its official documentation [3][4]. - Other legitimate products have also been falsely marketed, such as a cold remedy claimed to prevent cancer and a calcium supplement marketed as a cure for osteoporosis [3][4]. Group 2: Market Chaos Causes - The increasing health anxiety among the elderly drives them to seek out exaggerated claims of health benefits, making them susceptible to misleading advertisements [4][6]. - Information asymmetry exists, as many elderly individuals lack sufficient knowledge about medications and health, making it difficult for them to discern the truth behind product claims [4][6]. - Some companies engage in unethical practices, altering product names and exaggerating benefits through various promotional channels, which exacerbates market confusion [6]. Group 3: Health Risks and Regulatory Needs - The fraudulent promotion of these so-called "miracle drugs" poses significant health risks, potentially delaying treatment for chronic conditions and causing adverse reactions [6]. - There is a call for stricter regulation from health authorities to combat false advertising and ensure truthful representation of product efficacy [6]. - Companies are urged to adhere to ethical marketing practices and consumers, particularly the elderly, should be educated to critically evaluate health claims [6].